Inhaled iloprost for therapy in pulmonary arterial hypertension

被引:0
作者
Ewert, Ralf [1 ]
Glaeser, Sven [1 ]
Bollmann, Tom [1 ]
Schaeper, Christoph [1 ]
机构
[1] Ernst Moritz Arndt Univ Greifswald, Dept Internal Med, Greifswald, Germany
关键词
inhaled iloprost; PAH; prostanoids; side effects of therapy; therapy algorithm; CALCIUM-CHANNEL BLOCKERS; LONG-TERM TREATMENT; STABLE PROSTACYCLIN ANALOG; AEROSOLIZED ILOPROST; ORAL SILDENAFIL; COMBINATION THERAPY; NITRIC-OXIDE; BOSENTAN; PHARMACOKINETICS; PHARMACODYNAMICS;
D O I
10.1586/ERS.11.14
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Iloprost (Ventavis (R), Bayer Schering Pharma, Germany) is a synthetic prostacyclin that is used in its inhalative form for the therapy of pulmonary arterial hypertension. Long-term therapy can increase exercise capacity and quality of life. The use of modern nebulizers especially designed for the administration of iloprost guarantees the pulmonary deposition of the required doses and systematically minimizes side effects. Regarding existing data, inhalative iloprost acts in effective and safe combination with other classes of medication; indeed, such combination therapy is frequently necessary in pulmonary arterial hypertension.
引用
收藏
页码:145 / 152
页数:8
相关论文
共 56 条
[31]  
Launay D, 2001, J RHEUMATOL, V28, P2252
[32]   Long-term treatment of pulmonary hypertension with aerosolized iloprost [J].
Machherndl, S ;
Kneussl, M ;
Baumgartner, H ;
Schneider, B ;
Petkov, V ;
Schenk, P ;
Lang, IM .
EUROPEAN RESPIRATORY JOURNAL, 2001, 17 (01) :8-13
[33]   Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension [J].
McLaughlin, Vallerie V. ;
Oucliz, Ronald J. ;
Frost, Aclaani ;
Tapson, Victor F. ;
Murali, Srinivas ;
Channick, Richard N. ;
Badesch, David B. ;
Barst, Robyn J. ;
Hsu, Henry H. ;
Rubin, Lewis J. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 174 (11) :1257-1263
[34]   Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension A Randomized Controlled Clinical Trial [J].
McLaughlin, Vallerie V. ;
Benza, Raymond L. ;
Rubin, Lewis J. ;
Channick, Richard N. ;
Voswinckel, Robert ;
Tapson, Victor F. ;
Robbins, Ivan M. ;
Olschewski, Horst ;
Rubenfire, Melvyn ;
Seeger, Werner .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (18) :1915-1922
[35]   Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension [J].
Montani, David ;
Savale, Laurent ;
Natali, Delphine ;
Jais, Xavier ;
Herve, Philippe ;
Garcia, Gilles ;
Humbert, Marc ;
Simonneau, Gerald ;
Sitbon, Olivier .
EUROPEAN HEART JOURNAL, 2010, 31 (15) :1898-1907
[36]   Inhaled iloprost to treat severe pulmonary hypertension -: An uncontrolled trial [J].
Olschewski, H ;
Ghofrani, HA ;
Schmehl, T ;
Winkler, J ;
Wilkens, H ;
Höper, MM ;
Behr, J ;
Kleber, FX ;
Seeger, W .
ANNALS OF INTERNAL MEDICINE, 2000, 132 (06) :435-+
[37]   Pharmacodynamics and pharmacokinetics of inhaled iloprost, aerosolized by three different devices, in severe pulmonary hypertension [J].
Olschewski, H ;
Rohde, B ;
Behr, J ;
Ewert, R ;
Gessler, T ;
Ghofrani, HA ;
Schmehl, T .
CHEST, 2003, 124 (04) :1294-1304
[38]   Inhaled iloprost for severe pulmonary hypertension [J].
Olschewski, H ;
Simonneau, G ;
Galiè, N ;
Higenbottam, T ;
Naeije, R ;
Rubin, LJ ;
Nikkho, S ;
Speich, R ;
Hoeper, MM ;
Behr, J ;
Winkler, J ;
Sitbon, O ;
Popov, W ;
Ghofrani, HA ;
Manes, A ;
Kiely, DG ;
Ewert, R ;
Siedentop, H ;
Seeger, W .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (05) :322-329
[39]   Aerosolized prostacyclin and iloprost in severe pulmonary hypertension [J].
Olschewski, H ;
Walmrath, D ;
Schermuly, R ;
Ghofrani, A ;
Grimminger, F ;
Seeger, W .
ANNALS OF INTERNAL MEDICINE, 1996, 124 (09) :820-824
[40]   Long-term therapy with inhaled iloprost in patients with pulmonary hypertension [J].
Olschewski, Horst ;
Hoeper, Marius M. ;
Behr, Juergen ;
Ewert, Ralf ;
Meyer, Andreas ;
Borst, Mathias M. ;
Winkler, Joerg ;
Pfeifer, Michael ;
Wilkens, Heinrike ;
Ghofrani, Hossein Ardeschir ;
Nikkho, Sylvia ;
Seeger, Werner .
RESPIRATORY MEDICINE, 2010, 104 (05) :731-740